BURST-AF TRIAL: Preliminary 12-month Data

In Case You Missed the “Sine”, Dr. Ante Anic Presented Preliminary 12-month Data from BURST-AF

Dr. Ante Anic, KBC Split Hospital, presented preliminary 12-month results from BURST-AF (NCT05572047) at the annual AF Symposium in Boston.

Highlights from the presentation included:

101 patients treated – 59% paroxysmal AF and 41% persistent AF
50 of 55 (90.9%) patients with paroxysmal AF and 28 of 34 (82.4%) of patients with persistent AF were free of AF/AFL/AT > 30s off antiarrhythmic drugs at 12-months
COHERENT-AF (NCT06784466), the IDE clinical trial designed to evaluate the safety and effectiveness of the CSE platform in paroxysmal and persistent AF is currently over 50% enrolled at participating centers in the US and Europe.